Krishnan K Ranga Rama
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center (3050A), 4584 Hospital South, Box 3950, Durham, NC 27710, USA.
Psychosom Med. 2005 Jan-Feb;67(1):1-8. doi: 10.1097/01.psy.0000151489.36347.18.
This review summarizes the literature on psychiatric and medical comorbidities in bipolar disorder. The coexistence of other Axis I disorders with bipolar disorder complicates psychiatric diagnosis and treatment. Conversely, symptom overlap in DSM-IV diagnoses hinders definition and recognition of true comorbidity. Psychiatric comorbidity is often associated with earlier onset of bipolar symptoms, more severe course, poorer treatment compliance, and worse outcomes related to suicide and other complications. Medical comorbidity may be exacerbated or caused by pharmacotherapy of bipolar symptoms.
Articles were obtained by searching MEDLINE from 1970 to present with the following search words: bipolar disorder AND, comorbidity, anxiety disorders, eating disorder, alcohol abuse, substance abuse, ADHD, personality disorders, borderline personality disorder, medical disorders, hypothyroidism, obesity, diabetes mellitus, multiple sclerosis, lithium, valproate, lamotrigine, carbamazepine, atypical antipsychotics. Articles were prioritized for inclusion based on the following considerations: sample size, use of standardized diagnostic criteria and validated methods of assessment, sequencing of disorders, quality of presentation.
Although the literature establishes a strong association between bipolar disorder and substance abuse, the direction of causality is uncertain. An association is also seen with anxiety disorders, attention-deficit/hyperactivity disorder, and eating disorders, as well as cyclothymia and other axis II personality disorders. Medical disorders accompany bipolar disorder at rates greater than predicted by chance. However, it is often unclear whether a medical disorder is truly comorbid, a consequence of treatment, or a combination of both.
To ensure prompt, appropriate intervention while avoiding iatrogenic complications, the clinician must evaluate and monitor patients with bipolar disorder for the presence and the development of comorbid psychiatric and medical conditions. Conversely, physicians should have a high index of suspicion for underlying bipolar disorder when evaluating individuals with other psychiatric diagnoses (not just unipolar depression) that often coexist with bipolar disorder, such as alcohol and substance abuse or anxiety disorders. Anticonvulsants and other mood stabilizers may be especially helpful in treating bipolar disorder with significant comorbidity.
本综述总结了有关双相情感障碍中精神疾病共病和躯体疾病共病的文献。其他轴I障碍与双相情感障碍并存会使精神疾病的诊断和治疗变得复杂。相反,《精神疾病诊断与统计手册》第四版(DSM-IV)诊断中的症状重叠阻碍了对真正共病的定义和识别。精神疾病共病通常与双相情感障碍症状的更早出现、病程更严重、治疗依从性更差以及与自杀和其他并发症相关的更糟结局有关。躯体疾病共病可能因双相情感障碍症状的药物治疗而加重或引发。
通过检索1970年至今的MEDLINE获取文章,检索词如下:双相情感障碍、共病、焦虑障碍、进食障碍、酒精滥用、物质滥用、注意力缺陷多动障碍(ADHD)、人格障碍、边缘型人格障碍、躯体疾病、甲状腺功能减退、肥胖症、糖尿病、多发性硬化症、锂盐、丙戊酸盐、拉莫三嗪、卡马西平、非典型抗精神病药物。基于以下考虑因素对文章进行优先纳入:样本量、标准化诊断标准的使用和经过验证的评估方法、疾病顺序、呈现质量。
尽管文献表明双相情感障碍与物质滥用之间存在密切关联,但因果关系的方向尚不确定。还发现双相情感障碍与焦虑障碍、注意力缺陷多动障碍和进食障碍以及环性心境障碍和其他轴II人格障碍有关联。躯体疾病伴随双相情感障碍出现的几率高于偶然预期。然而,通常不清楚一种躯体疾病是否真的是共病、是治疗的结果还是两者的结合。
为确保及时、恰当的干预,同时避免医源性并发症,临床医生必须评估和监测双相情感障碍患者是否存在共病的精神疾病和躯体疾病及其发展情况。相反,在评估患有其他常与双相情感障碍并存的精神疾病诊断(不仅仅是单相抑郁)的个体时,如酒精和物质滥用或焦虑障碍,医生应高度怀疑其潜在的双相情感障碍。抗惊厥药和其他心境稳定剂可能对治疗伴有显著共病的双相情感障碍特别有帮助。